Is it surprising that Neil Woodford has been adding to these holdings?

Neil Woodford is one of the best known investment managers in the UK, but you might be surprised by his latest share purchases.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Neil Woodford is one of the most renowned fund managers in the UK and when Woodford purchases shares in a company, the investment world takes notice. The fund manager made some adjustments to his Equity Income portfolio in late September, and you might be surprised about the holdings he added to.

Profit warning  

The largest performance detractor for Woodford’s fund in September was Capita (LSE: CPI), which issued an unscheduled trading statement in late September, downgrading profit expectations. The outsourcing giant blamed a slowdown in trading businesses, one-off costs incurred on the TfL congestion charging contract and delays in client decision making. It informed investors that it was now expecting profit before tax of £535m-£555m, around 10%-13% lower than consensus estimates at the time.

Capita’s share price, which had been trading around the 1,000p before the news, dropped like a stone on the profit warning, falling around 40% in the space of a week to the 600p mark. Analysts were quick to downgrade their earnings estimates for the company.

However, not one to panic, Woodford took a rational approach to the profit warning, meeting with Capita management to discuss the issues. The fund manager came away from the meeting reassured that an equity issue wouldn’t be required, that the dividend remains safe, and that Capita was already working through the problems “in order to restore the business to a healthier growth trajectory.

Woodford believes the market reaction to the profit warning was “disproportionate” and took the opportunity to add to his holding at the end of September at the depressed price.  

City analysts now anticipate Capita generating earnings and dividends per share of 67p and 32p respectively for FY2016, which at the current share price equates to a forecast P/E ratio of 8.5 and a dividend yield of 5.6%.

These figures certainly look attractive at face value, and while many analysts aren’t positive on the stock, Woodford obviously sees something he likes in Capita.

Long-term growth drivers

Another stock that Woodford added to in September was Legal & General Group (LSE: LGEN), trimming his position in Roche to fund the top-up.

City analysts aren’t overly excited about Legal & General’s short-term prospects either, with 11 of the 20 analysts covering the stock rating the company as a hold. However, perhaps Woodford is looking at the long-term growth drivers of the insurance giant such as ageing populations and welfare reform as the key to unlocking shareholder value here. Indeed, chief executive Nigel Wilson recently stated that the firm’s long-term growth drivers “remain unaffected [by Brexit] and will continue to provide many growth opportunities.

There’s no doubt it’s been a pretty lousy 18 months for shareholders in Legal & General, with the share price slowly drifting down from within a whisker of 300p in March 2015 to 208p today. However, with analysts pencilling-in earnings and dividends of 21p and 14p per share respectively for FY2016, that leaves the insurer with a dividend yield of a formidable 6.7% and a forecast P/E ratio of just 9.9.

With Brexit uncertainty still in the air, the super high yield suggests that the market isn’t quite convinced about Legal & General’s prospects. However, with a sizeable 4.8% holding in his Equity Income Fund, Woodford is clearly happy to go against the crowd.

Edward Sheldon owns shares in Legal & General Group. The Motley Fool UK has no position in any of the shares mentioned. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Middle-aged white man pulling an aggrieved face while looking at a screen
Market Movers

Down 7%! Why on earth are Imperial Brands shares plummeting today?

Imperial Brands shares are in freefall after a negative reception to fresh trading news. Is the party finally over for…

Read more »

Rear View Of Woman Holding Man Hand during travel in cappadocia
Investing Articles

With a P/E under 7, this value stock looks far too cheap at 101p

This writer reckons value stock Hostelworld (LSE:HSW) looks dirt-cheap as it gets dividends flowing again and builds a social travel…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing For Beginners

Down 30% in 6 months, I think there’s a big catch to this insanely cheap stock

Jon Smith talks through why careful research is needed when trying to assess if a cheap stock is worth buying…

Read more »

Investing Articles

£5,000 invested in National Grid shares 5 years ago is now worth…

Andrew Mackie takes a closer look at National Grid shares and why short-term market weakness could be missing a powerful…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

How big does an ISA need to be to aim for a £1,500 monthly second income?

Harvey Jones shows how building a balanced portfolio of FTSE 100 dividend stocks can produce a high-and-rising second income in…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

£20,000 invested in BP shares 1 year ago is now worth…

BP shares have rocketed in the past 12 months, yet analysts think the real growth story is only just beginning,…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

A 6.8% forecast yield! 1 often-overlooked FTSE 100 income stock to buy today?

This income stock offers a high forecast yield and strengthening momentum, yet many investors overlook it — creating a rare…

Read more »

GSK scientist holding lab syringe
Investing Articles

GSK’s share price is under £22, but with a ‘fair value’ much higher, is it time for me to buy more right now? 

GSK’s share price rose over the last year, but a huge gap remains between its price and fair value —…

Read more »